Randall Moreadith's Transactions in Serina Therapeutics, Inc. Common Stock

On October 27, 2025, Randall Moreadith, the Chief Scientific Officer of Serina Therapeutics, Inc., engaged in several transactions involving the company's common stock. Moreadith acquired 949 shares at $0.06 per share and subsequently sold the same number of shares at a weighted average price of $5.1857. Additionally, Moreadith disposed of 949 stock options (right to buy) with an exercise price of $0.06 per share. The stock options were fully vested. Following these transactions, Moreadith no longer holds any common stock but retains 409,737 stock options. The transactions were reported in a Form 4 filing with the SEC.